n-2-hexyl-n-methylpropargylamine has been researched along with amphetamine in 1 studies
Studies (n-2-hexyl-n-methylpropargylamine) | Trials (n-2-hexyl-n-methylpropargylamine) | Recent Studies (post-2010) (n-2-hexyl-n-methylpropargylamine) | Studies (amphetamine) | Trials (amphetamine) | Recent Studies (post-2010) (amphetamine) |
---|---|---|---|---|---|
9 | 0 | 0 | 13,071 | 329 | 1,977 |
Protein | Taxonomy | n-2-hexyl-n-methylpropargylamine (IC50) | amphetamine (IC50) |
---|---|---|---|
Phenylethanolamine N-methyltransferase | Bos taurus (cattle) | 0.96 | |
Cytochrome P450 2A6 | Homo sapiens (human) | 3.5 | |
Cytochrome P450 2A5 | Mus musculus (house mouse) | 2.85 | |
Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.96 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.96 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boulton, AA; Davis, BA; Yu, PH | 1 |
1 review(s) available for n-2-hexyl-n-methylpropargylamine and amphetamine
Article | Year |
---|---|
Aliphatic propargylamines, a new series of potent selective, irreversible non-amphetamine-like MAO-B inhibitors. Their structures, function and pharmacological implications.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amphetamine; Animals; Mice; Monoamine Oxidase Inhibitors; Pargyline; Propylamines; Structure-Activity Relationship | 1995 |